Literature DB >> 188364

Role of triglyceride-rich lipoproteins in atherogenesis.

D B Zilversmit.   

Abstract

The hypothesis that chylomicron cholesterol is a causal factor in the accumulation of cholesterol in atheromatous lesions is compatible with the finding reported here that hypercholesterokmia in the cholesterol-fed rabbit is due, at least, in part, to the accumulation of chylomicron remnants. The presence of lipoprotein lipase in aorta suggests the possibility that chylomicron remnants are formed on the arterial surface and that they may be deposited in the deeper layers of the arterial wall without prior release into the bloodstream. Consequently, the cholesterol-rich lipo-proteins in the plasma may be the product rather than the precursor of the atherogenic process.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 188364     DOI: 10.1111/j.1749-6632.1976.tb43348.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

Review 1.  Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments.

Authors:  N E Miller
Journal:  J Clin Pathol       Date:  1979-07       Impact factor: 3.411

2.  [Effect of diurnal distribution of food intake on 24-h profiles of plasma lipoproteins (author's transl)].

Authors:  J Schneider; H Tauber
Journal:  Klin Wochenschr       Date:  1981-02-16

3.  A little more time around the track may go a long way: Implications of increasing moderate to vigorous physical activity in pre-adolescents.

Authors:  Zareen Farukhi; Samia Mora
Journal:  Atherosclerosis       Date:  2019-06-29       Impact factor: 5.162

4.  The role of lipoprotein lipase in metabolism of normolipidemic very low density lipoprotein by macrophages.

Authors:  S P Wang; Y M Feng; Z C Feng; W S Wu; C B Wang; C R An; W G Jiang
Journal:  J Tongji Med Univ       Date:  1989

5.  Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.

Authors:  Zareen M Farukhi; Olga V Demler; Michael P Caulfield; Krishnaji Kulkarni; Jay Wohlgemuth; Michael Cobble; Heike Luttmann-Gibson; Chunying Li; John R Nelson; Nancy R Cook; Julie E Buring; Ronald M Krauss; JoAnn E Manson; Samia Mora
Journal:  J Clin Lipidol       Date:  2020-02-21       Impact factor: 4.766

6.  Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice.

Authors:  Tatjana Josefs; Debapriya Basu; Tomas Vaisar; Britt Arets; Jenny E Kanter; Lesley-Ann Huggins; Yunying Hu; Jianhua Liu; Noemie Clouet-Foraison; Jay W Heinecke; Karin E Bornfeldt; Ira J Goldberg; Edward A Fisher
Journal:  Circ Res       Date:  2021-02-03       Impact factor: 17.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.